PRE

Prenetics Global Limited operates as a diagnostics and genetic testing company specializing in prevention-focused healthcare solutions. Headquartered in Hong Kong, the company delivers personalized health insights through direct-to-consumer genetic testing and clinical diagnostic services across Asia, Europe, and North America. Prenetics operates through two primary business segments: consumer genetics, led by its CircleDNA brand offering comprehensive DNA testing for health, nutrition, and ancestry; and diagnostic testing, powered by ACT Genomics, which provides precision oncology and cancer screening services to healthcare providers. The company gained prominence during the COVID-19 pandemic by establishing one of the world's largest testing networks, processing millions of tests across multiple countries. Prenetics became publicly traded in May 2022 through a SPAC merger with Artisan Acquisition Corp, listing on NASDAQ under ticker PRE. The company has strategically acquired several entities to expand its capabilities, including DNAfit in 2020 to strengthen its consumer genetics platform and Insightful in 2021 to enhance its Southeast Asian presence. Prenetics operates CLIA-certified and CAP-accredited laboratories and maintains partnerships with major institutions and corporations. The company employs several hundred staff across its global operations and continues to invest in expanding its genomic database and AI-driven health analytics capabilities to differentiate its precision health offerings in the growing preventive care market.